← Back to Markets

DRMA

Dermata Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology

$1.35+$0.03 (+2.27%)

Prices delayed up to 5 minutes

AC Intelligence

AC Intelligence

AC Intelligence for DRMA is being prepared.

Key Stats

Key Stats

Open

$1.33

Day High

$1.37

Day Low

$1.26

Prev Close

$1.32

Volume

0

Avg Volume

466.4K

Day Change

+$0.03

Change %

+2.27%

Fundamentals

Fundamentals

P/B

0.38

EPS (TTM)

$-9.42

Market Cap

$5M

52-Wk Range

$1.10 — $9.90

Earnings History

Insider Activity

Who Owns This Stock

Who Owns DRMA

Tactical / Macro63.2%1 holder
Dealer / Bank20.0%3 holders
Other16.7%3 holders

Based on Q4 2025 13F filings + AC behavioral model

7 institutional holders

Top Holders

1.Clear Street Group Inc.
$39.4B
2.Bank of America Corp
$7.1B
3.Barclays PLC
$5.6B
4.Tower Research Capital LLC (TRC)
$4.6B
5.UBS Group AG
-88.9%$2.6B
6.JPMORGAN CHASE & CO
$1.6B
7.Bank of America Corp
$928M
8.UBS Group AG
-98.8%$290M
9.SBI Securities Co., Ltd.
0.0%$234M
10.Bank of America Corp
0.0%$9M

Institutional Pressure

Market Regime:Strong Risk-Off (-0.62)
SELLINGBUYING
Heavy Selling Pressure
Tactical / Macro(63.2%)
Reducing rapidly
Dealer / Bank(20.0%)
Facilitating
Other(16.7%)

Updated daily · Based on Q4 2025 filings + AC behavioral model

Sentiment Signals

Sentiment Signals

Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus6 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows6 increased/new, 2 decreased/exited (13F)AC 13F Analysis

Sources: SEC Form 4, Finnhub, AC 13F Analysis

On AcidCapitalist

On AcidCapitalist

No recent mentions of DRMA on AcidCapitalist.

Data provided by Finnhub. Prices delayed up to 5 minutes.